-

11:59:48 AM

PRPH Stock News

PRPH - ProPhase Labs Inc

01/13/22 8:15 AM

Nasdaq : PRPH

covid-19low float

ProPhase Labs Announces Record COVID-19 Testing in Q4 2021

ProPhase Labs, Inc. (NASDAQ: PRPH), a diversified biotech and genomics company,

RHEA-AI

neutral

01/05/22 8:30 AM

Nasdaq : PRPH

conferenceslow float

ProPhase Labs to Present at the H.C. Wainwright Bioconnect 2022 Virtual Conference

ProPhase Labs, Inc. (Nasdaq: PRPH), a diversified biotech and genomics company, announces today that Chairman and CEO Ted Karkus will present a corporate overview at the H.C. Wainwright Bioconnect 2022 Virtual Conference, which is taking place on

RHEA-AI

neutral

12/16/21 8:30 AM

Nasdaq : PRPH

low float

ProPhase Labs Continues to Build Strong Leadership with Key Promotions and Additions to Management Team

RHEA-AI

very positive

11/23/21 4:15 PM

Nasdaq : PRPH

low float

PROPHASE LABS, INC. ANNOUNCES INDUCEMENT AWARD UNDER NASDAQ LISTING RULE 5635(C)(4)

ProPhase Labs, Inc. (Nasdaq: PRPH), a diversified biotech and genomics company, today announced that it has granted an inducement award to a new employee. ProPhase granted a stock option to purchase 100,000 shares of common stock to this employee

RHEA-AI

very positive

11/12/21 8:30 AM

Nasdaq : PRPH

earningslow float

ProPhase Labs Announces Financial Results for the Three Months Ended September 30, 2021

ProPhase Labs, Inc. (NASDAQ: PRPH), a diversified biotech and genomics company, today reported its financial and operational results for the three months ended September 30,

RHEA-AI

neutral

11/10/21 8:30 AM

Nasdaq : PRPH

conferenceslow float

ProPhase Labs to Present at the Q4 Investor Summit Conference

ProPhase Labs, Inc. (Nasdaq: PRPH), a diversified biotech and genomics company, announces today that Chairman and CEO Ted Karkus will present at the Q4 Investor Summit Conference, which is being held virtually from November 16 – 17, 2021. Mr.

RHEA-AI

neutral

11/05/21 8:30 AM

Nasdaq : PRPH

conferencesearningslow float

ProPhase Labs to Host Third Quarter 2021 Financial Results Conference Call on Friday, November 12, 2021 at 11:00 a.m. Eastern Time

ProPhase Labs, Inc. (NASDAQ: PRPH), a diversified biotech and genomics company, will hold a conference call on Friday, November 12, 2021 at 11:00 a.m. Eastern time to discuss its results for the third quarter ended September 30, 2021. A press

RHEA-AI

neutral

10/13/21 8:30 AM

Nasdaq : PRPH

low float

ProPhase Labs Provides Business Update

ProPhase Labs, Inc. (NASDAQ: PRPH), a diversified biotech and genomics company, today announces that it expects its Q3 2021 COVID-19 testing revenues to be lower than its Q2 2021 testing revenues given the overall lower levels of COVID-19 testing

RHEA-AI

neutral

10/06/21 8:30 AM

Nasdaq : PRPH

conferenceslow float

ProPhase Labs to Present at the LD Micro Main Event Conference

ProPhase Labs, Inc. (Nasdaq: PRPH), a diversified biotech and genomics company, announces today that Chairman and CEO Ted Karkus will be presenting virtually at the 14 th Annual LD Micro Main Event Conference. Mr. Karkus will deliver his

RHEA-AI

neutral

09/22/21 8:30 AM

Nasdaq : PRPH

conferenceslow float

ProPhase Labs to Present at the Benzinga Healthcare Small Cap Conference

ProPhase Labs, Inc. (Nasdaq: PRPH), a diversified biotech and genomics company, announces today that Chairman and CEO Ted Karkus will present at the Benzinga Healthcare Small Cap Conference, which is being held virtually from September 29 – 30,

RHEA-AI

neutral

PRPH Data:

IndustryPharmaceutical Preparation Manufacturing
Websitewww.prophaselabs.com
Security nameProPhase Labs Inc
Issue typecs
SectorManufacturing
Sic code2834
Employees95
Tags
- Consumer Non-Durables
- Household/Personal Care
- Health Technology
- Pharmaceuticals: Major
- Manufacturing
- Pharmaceutical Preparation Manufacturing

PRPH Description:

ProPhase Labs is a diversified medical science and technology company with deep experience with OTC consumer healthcare products and dietary supplements. The Company is engaged in the research, development, manufacture, distribution, marketing and sale of OTC consumer healthcare products and dietary supplements in the United States. This includes the development and marketing of dietary supplements under the TK Supplements® brand. The Company is also developing ProPhase Diagnostics, Inc. ("ProPhase Diagnostics") to offer COVID-19 and other Respiratory Pathogen Panel (RPP) Molecular tests. The Company also continues to actively pursue strategic investments and acquisition opportunities for other companies, technologies and products.